MabCure Secures $10M Commitment from An Institutional Investor
MabCure Inc. secured a $10 million funding commitment from Centurion Private Equity LLC. MabCure is a New York-based biotechnology company. It plans to use proceeds to fund clinical trials and ongoing research and development efforts. The company also plans to use the funds for general corporate purposes. Centurion is an institutional investor managed by Roswell Capital Partners LLC of Alpharetta, Ga.
21 January 2011•3 mins read
